Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Optimization and Formulation of Orodispersible Tablets of Meloxicam

Jashanjit Singh¹ , Rajmeet Singh²

¹Department of Pharmaceutics, Swift School of Pharmacy, Village- Gaagar Sarai,Rajpura; ²Department of Pharmaceutics ,GHG Khalsa College of Pharmacy, Guru Sar Sadhar, Ludhiana,Punjab, India.

For correspondence:- Jashanjit Singh Email: jasnirman@rediffmail.com Tel:+919814819282

Received: 29 September 2008 Accepted: 28 December 2008 Published: 17 April 2009

Citation: Singh J, Singh R. Optimization and Formulation of Orodispersible Tablets of Meloxicam. Trop J Pharm Res 2009; 8(2):153-159 doi: 10.4314/tjpr.v8i2.9

© 2009 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: The objective of this study was to formulate and optimize an orodispersible formulation of meloxicam using a 2² factorial design for enhanced bioavailability.

Methods: The tablets were made by non-aqueous wet granulation using crospovidone and mannitol. A 2² factorial design was used to investigate the amount of crospovidone and taste masking, soothening hydrophilic agent (mannitol), as independent variables, and disintegration time as dependent response. Formulated orodispersible tablets were evaluated for weight variation, friability, disintegration time, drug content, wetting time, water absorption ratio and in vitro drug release.

Results: The results show that the presence of a superdisintegrant and mannitol is desirable for orodispersion. All the formulations satisfied the limits of orodispersion with a dispersion time of less than 60 sec. For example, formulation F₄showed a disintegration time of 32.1 sec, crushing strength of 4.93 kg/cm², drug content of 98.5% and fast drug release rate of 99.5% within 30 min, as compared with the conventional tablet (49.5%) .

Conclusion: It is feasible to formulate orodispersible tablets of meloxican with acceptable disintegration time, rapid drug release and good hardness, which could be amenable to replication on an industrial scale.

Keywords: Meloxicam, Orodispersion, Crosspovidone, Mannitol, Factorial design, Tablet properties